Skip to search formSkip to main contentSkip to account menu

Classical Hodgkin's Lymphoma

Known as: CHL, Classical Hodgkin Lymphoma 
A monoclonal B-cell lymphoproliferation in the vast majority of cases. It is characterized by a bimodal age distribution (15-30 years of life and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Due to disease rarity, there is limited information regarding the optimal therapy and outcome for patients with advanced-stage… 
Highly Cited
2013
Highly Cited
2013
PURPOSE The immune microenvironment is key to the pathophysiology of classical Hodgkin lymphoma (CHL). Twenty percent of patients… 
Highly Cited
2012
Highly Cited
2012
In classical Hodgkin lymphoma (CHL), 20%-30% of patients experience relapse or progressive disease after initial treatment. The… 
Review
2009
Review
2009
  • E. Jaffe
  • 2009
  • Corpus ID: 5910575
The 4(th) edition of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues published in 2008 builds upon the… 
Highly Cited
2004
Highly Cited
2004
The pigment compositions of 37 species (65 strains) of cultured haptophytes were analysed using improved HPLC methods. We… 
Highly Cited
2004
Highly Cited
2004
Primary mediastinal large B-cell lymphoma (PMBL), currently recognized as a diffuse large B-cell lymphoma (DLBCL) subtype, shows… 
Highly Cited
2002
Highly Cited
2002
Comparative genomic hybridization studies have shown gains in chromosome region 2p as the most common imbalance in classical… 
Highly Cited
1997
Highly Cited
1997
We apply an objective statistical analysis to a 6-yr, multiparameter dataset in an effort to describe the spatial dependence and… 
Highly Cited
1975
Highly Cited
1975
The genetics of low-level resistance to penicillin and other antibiotics in a clinical isolate and a multistep laboratory mutant…